EU Strikes Deal With Pfizer to Cut Covid Vaccine Purchases
A vial of the Pfizer-BioNTech Covid-19 vaccine at a clinic inside Trinity Evangelic Lutheran Church in Lansdale, Pennsylvania, U.S, on Tuesday, Apr. 5, 2022. U.S. regulators cleared second booster doses of Covid-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.